Elutia Inc. (ELUT) Stock Price & Analysis

Elutia Inc. (ELUT) closed at USD 0.79 on Thursday, October 15, 2026, up 7.32% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 0.74; the Oct 15, 2026 session ranged USD 0.71–0.8 on volume of 123,877 shares. Market capitalization is $34.94M, with a 52-week range of USD 0.5–1.39 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:22 UTC.

Also available as compact Markdown for AI agents: nexqual.com/ELUT.md

Key facts (ELUT)

Analysts (ELUT)

Consensus Buy (mean 2.00 on a 1–5 scale), 1 analysts; mean target USD 5 (low 5, high 5).

Total return (dividends reinvested) (ELUT)

1Y (from 2025-10-16)5Y (from 2021-10-11)
Total return-12.3%-85.5%
S&P 500 (SPY)+18.1%+85.1%
Per year-12.4%-32.0%
Volatility (annualized)73.8%91.3%
Max drawdown-47.4% (Nov 2025→Dec 2025)-93.3% (Oct 2022→Dec 2025)

Key Statistics (as of October 16, 2026 at 05:22 UTC)

PriceUSD 0.79
Change▲ 7.32% (up)
Previous CloseUSD 0.74
OpenUSD 0.72
Day RangeUSD 0.71 – 0.8
52-Week RangeUSD 0.5 – 1.39
Volume123,877 shares
Market Cap$34.94M
ExchangeNCM

Technical Analysis (ELUT)

Nexqual's technical model rates ELUT "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:22 UTC.

Overall SignalSTRONG SELL
RSI (14)45.46 (neutral)
vs SMA50Below (USD 0.84)
MACD-0.02 (negative)

Analyst Ratings (ELUT)

Wall Street analysts rate ELUT "Buy" based on 1 analysts, with a mean price target of USD 5 (range USD 5–5), per Nexqual as of October 16, 2026 at 05:22 UTC.

Consensus RatingBuy
Analyst Count1
Mean TargetUSD 5
High TargetUSD 5
Low TargetUSD 5
Buy / Hold / Sell1 / 0 / 0

Earnings (ELUT)

Next Earnings Date2026-11-12
Revenue Estimate$1.00M

Recent Earnings History

QuarterActual vs Estimate
2026-06-30USD -0.17 vs est -0.15 ▼ miss
2026-03-31USD -0.17 vs est -0.15 ▼ miss
2025-12-31USD 1.48 vs est -0.14 ▲ beat
2025-09-30USD -0.09 vs est -0.16 ▲ beat

Source: Nexqual, October 16, 2026 at 05:22 UTC.

Financials & Fundamentals (ELUT)

Total Revenue$12.14M
Revenue Growth (latest quarter, YoY)-11.60%
Gross Margin+57.76%
Operating Margin-243.10%
Profit Margin+426.90%
Debt / Equity0.28
Current Ratio1.77
Total Cash$19.90M
Total Debt$4.38M

Source: Nexqual, October 16, 2026 at 05:22 UTC.

Financial Health Score (ELUT)

Nexqual rates Elutia Inc.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:22 UTC.

GrowthCritical — Revenue -50% YoY (annual), sharp decline
ProfitabilityCritical — Heavily loss-making — early-stage company
Balance SheetStrong — $20M cash vs $4M debt, net cash position
Cash FlowWeak — Operating cash flow -$44M (TTM)
EfficiencyMixed — No data

Ownership (ELUT)

Insider Ownership+3.58%
Institutional Ownership+43.82%
Shares Outstanding44.29M
Float29.48M
Short % of Float+0.02%

Source: Nexqual, October 16, 2026 at 05:22 UTC.

Leadership (ELUT)

Elutia Inc. is led by C. Randal Mills (age 53), Co-Founder, President, CEO & Director, per Nexqual as of October 16, 2026 at 05:22 UTC.

Co-Founder, President, CEO & DirectorC. Randal Mills (age 53)
Chief Financial OfficerMatthew B. Ferguson (age 57)
Chief Scientific OfficerMichelle LeRoux Williams (age 50)

Major Backers & Investors (ELUT)

Notable institutional backers of Elutia Inc. include Nantahala Capital Management, LLC, AIGH Capital Management LLC, Knollwood Investment Advisory, LLC, according to Nexqual as of October 16, 2026 at 05:22 UTC.

Active Investors

InvestorStake
Nantahala Capital Management, LLC7.19%
AIGH Capital Management LLC6.09%
Knollwood Investment Advisory, LLC5.77%
SilverArc Capital Management, LLC4.95%
Perkins Capital Management, Inc.1.57%
Corient Private Wealth LP0.57%
Fidelity0.51%
Renaissance Technologies0.46%

Index Funds (Passive)

FundStake
Vanguard Group5.54%
Geode Capital0.64%

Source: Nexqual, October 16, 2026 at 05:22 UTC.

Peers & Related Stocks

SymbolNamePriceChange
ESTAEstablishment Labs Holdings IncUSD 61.36▲ 4.98%
ALMRAlamar Biosciences, Inc.USD 27.42▲ 16.58%
INSPInspire Medical Systems, Inc.USD 70.12▲ 1.83%
BFLYButterfly Network, Inc.USD 7.85▼ 3.09%
AXGNAxoGen, Inc.USD 35.63▼ 1.49%
UFPTUFP Technologies, Inc.USD 297.19▲ 0.99%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:22 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt